| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | NFLX | Non-qualified Stock Option (right to buy) | Options Exercise | $0 | -66 | -34.92% | $0.00 | 123 | Jan 31, 2023 | Common Stock | 66 | $329.81 | Direct | F4, F5 |
| transaction | NFLX | Non-qualified Stock Option (right to buy) | Options Exercise | $0 | -20 | -6.39% | $0.00 | 293 | Jan 31, 2023 | Common Stock | 20 | $199.46 | Direct | F4, F5 |
| transaction | NFLX | Non-qualified Stock Option (right to buy) | Options Exercise | $0 | -21 | -6.48% | $0.00 | 303 | Jan 31, 2023 | Common Stock | 21 | $192.91 | Direct | F4, F5 |
| transaction | NFLX | Non-qualified Stock Option (right to buy) | Options Exercise | $0 | -22 | -6.34% | $0.00 | 325 | Jan 31, 2023 | Common Stock | 22 | $179.95 | Direct | F4, F5 |
| transaction | NFLX | Non-qualified Stock Option (right to buy) | Options Exercise | $0 | -18 | -6.5% | $0.00 | 259 | Jan 31, 2023 | Common Stock | 18 | $226.21 | Direct | F4, F5 |
| transaction | NFLX | Non-qualified Stock Option (right to buy) | Options Exercise | $0 | -17 | -6.27% | $0.00 | 254 | Jan 31, 2023 | Common Stock | 17 | $230.04 | Direct | F4, F5 |
| transaction | NFLX | Non-qualified Stock Option (right to buy) | Options Exercise | $0 | -17 | -6.49% | $0.00 | 245 | Jan 31, 2023 | Common Stock | 17 | $239.04 | Direct | F4, F5 |
| transaction | NFLX | Non-qualified Stock Option (right to buy) | Options Exercise | $0 | -14 | -6.42% | $0.00 | 204 | Jan 31, 2023 | Common Stock | 14 | $286.75 | Direct | F4, F5 |
| transaction | NFLX | Non-qualified Stock Option (right to buy) | Options Exercise | $0 | -13 | -6.6% | $0.00 | 184 | Jan 31, 2023 | Common Stock | 13 | $316.95 | Direct | F4, F5 |
| transaction | NFLX | Non-qualified Stock Option (right to buy) | Options Exercise | $0 | -14 | -6.6% | $0.00 | 198 | Jan 31, 2023 | Common Stock | 14 | $294.95 | Direct | F4, F5 |
| Id | Content |
|---|---|
| F1 | Acquisition by Technology Crossover Management VII, L.P. ("TCM VII") pursuant to an in kind pro-rata distribution by each of TCV VII, L.P. and TCV VII (A), L.P. to each of its respective partners, without consideration. |
| F2 | These shares are directly held by TCM VII. Jay C. Hoag is a Class A Director of Technology Crossover Management VII, Ltd. ("Management VII") and a limited partner of TCM VII. Management VII is the sole general partner of TCM VII. Mr. Hoag may be deemed to beneficially own the shares held by TCM VII but disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein. |
| F3 | In kind pro-rata distribution from TCM VII to its partners, without consideration. |
| F4 | Jay C. Hoag has sole voting and dispositive power over the options he holds directly. However, TCV VII Management, L.L.C. has a right to 100% of the pecuniary interest in such options. Mr. Hoag is a Member of TCV VII Management, L.L.C. Mr. Hoag disclaims beneficial ownership of such options and the shares to be received upon the exercise of such options except to the extent of his pecuniary interest therein. |
| F5 | Jay C. Hoag has sole voting and dispositive power over the remaining options he holds directly. However, TCV VIII Management, L.L.C. has a right to 100% of the pecuniary interest in such remaining options. Mr. Hoag is a Member of TCV VIII Management, L.L.C. Mr. Hoag disclaims beneficial ownership of such options and the shares to be received upon the exercise of such options except to the extent of his pecuniary interest therein. |
This is the second and final part of a Form 4 filing for the Reporting Person. There are two parts to this Form 4 filing because of the constraint of a 30 transaction line maximum for tables in a Form 4.